Skip to main content

Jupiter Neurosciences, Inc.

JUNS
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001679628

No open-market purchases or sales by Jupiter Neurosciences, Inc. insiders were filed in the last 90 days; 13 institutions reported holding it in 13F filings for Q2 2026, worth $826.9K in total; no superinvestor holds it.

Open-market trades, last 90 days

Open-market purchases (P) and sales (S) by Jupiter Neurosciences, Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.

Open-market buys
0 filings
Open-market sells
0 filings
Insiders trading
0
Net value
$0
Purchases minus sales

Insider roster

Directors, officers and 10% owners who have filed a Form 4 for Jupiter Neurosciences, Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.

Insider roster for Jupiter Neurosciences, Inc.
NameTitleLast reported holdingLast filingFilings, past year
Cutler Andrew JonDirector–Aug 5, 20261
Kampf Julie B.Director82,875Jul 13, 20262
Rosen Alexander Gustaf ErikChief Administrative Officer617,411Jul 13, 20262
Hayward Marshall A.Chief Scientific Officer2,995,077Jul 13, 20262
Hemmerly Nicholas H.Director95,550Jul 13, 20262
Weis HolgerDirector96,581Jul 13, 20262
Philipson Tomas JanDirector–Jul 1, 20261
Brady Allison WDirector21,750Jun 5, 20261
Rosen ChristerCEO and Chairman11,078,892Jun 4, 20261
Elmasri SaleemChief Financial Officer66,239Jun 4, 20261
Silva Alison D.President and COO112,777Jun 4, 20261

Insider trades

Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Jul 3, 2025 (view filing)Jul 12 daysSilva Alison D.Pres + Chief Business OfficerPPurchase+750$1.03+$772.5+0.7%112.8K after3 lots
Jul 3, 2025 (view filing)Jul 12 daysRosen ChristerCEO and ChairmanPPurchase+3.60K$1.02+$3.67K0.0%11.1M after2 lots
Jul 1, 2025 (view filing)Jun 27-304 daysSilva Alison D.Pres + Chief Business OfficerPPurchase+1.80K$1.03+$1.86K+1.6%112.0K after9 lots
Jul 1, 2025 (view filing)Jun 27-304 daysRosen ChristerCEO and ChairmanPPurchase+7.82K$1.02+$7.99K+0.1%11.1M after7 lots